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Provision of end-of-life care in North America takes place across a multitude of settings, including hospitals, ambulatory clinics
andhomesettings.Asaresult,familycaregiving ischaracteristicallyamajorcomponentofcarewithinthehome.Accordingly,eco-
nomic evaluation of the end-of-life care environment must devote equal consideration to resources provided by the public health
system as well as privately ﬁnanced resources, such as time and money provided by family caregivers. This paper addresses the
methods used to measure end-of-life care costs. The existing empirical literature will be reviewed in order to assess care costs with
areas neglected in this body of literature to be identiﬁed. The Ambulatory and Home Care Record, a framework and tool for com-
prehensively measuringcosts related to the provision andreceipt ofend-of-life care across allhealthcare settings, willbe described
and proposed. Finally, areas for future work will be identiﬁed, alongwith their potential contribution to this body of knowledge.
1.Introduction
Health care restructuring in North America has resulted
in an increased emphasis on ambulatory and home-based
e n d - o f - l i f ec a r e[ 1]. Home-based healthcare services are
characterized by limited resources and escalating healthcare
costs. In some areas, publicly ﬁnanced home-based end-of-
life programs have been established to provide community
care and team-based multidisciplinary care to individuals at
home. While the home environment is often the ﬁrst choice
forpatientsandfamilymembers, home-basedcaremayplace
higher demands on family members, particularly when a
patient has complex and immediate health care needs and
is close to death.
Although a high proportion of home-based end-of-life
care is provided by family caregivers, little empirical atten-
tion has been devotedto the identiﬁcation and measurement
of the full range of costs incurred by patients and their
caregivers. Most economic analyses of home-based care are
limited to measurement of publicly ﬁnanced care. Despite
the fact that a high proportion of end-of-life care is provided
by family caregivers, particularly in the home setting, time
spent by these caregivers is often perceived as having no
or minimal monetary value [2]. Time allocations to care, if
not provided by family caregivers, may have necessitated the
acquisition of a privately funded caregiver. Measuring only
health system costs, whether publicly or privately ﬁnanced,
may therefore lead to an inaccurate estimate of relative
resource costs associated with alternative health care settings
or interventions, particularly when family costs represent a
large portion of overall costs.
In this paper, we discuss the methodological aspects
of end-of-life care costs. Methodological elements of the
empirical literature will be presented and areas that have
beenneglectedinthisbody ofliteraturewill beidentiﬁed.We
present the Ambulatory and Home Care Record (AHCR), a
framework and tool to inform future research that measures
end-of-life care costs from a societal perspective [2–4].
Measuring costs from a societal perspective dictates that all
resource costs, irrespective of payer, be considered. Finally,
research areas that can be addressed using the AHCR
methodological framework and tool will be identiﬁed and
the potential contribution of these suggested topics will be
provided.2 Journal of Aging Research
2.EconomicEmpiricalStudieson
End-of-LifeCare
Theeconomicresearch literatureonend-of-lifecarehasbeen
dominated by studies measuring publicly ﬁnanced health
services;fewstudieshaveexaminedcostsincurredbypatients
and theircaregivers. Excludingpatient and caregiverresource
costs in studies comparing home-based care to in-patient
care resultsin underestimates ofthe value,types, and sources
of resources consumed in various health care settings. The
absence of information on the costs of an episode of end-of-
lifecarelimitshealthplanningandmayundulyrestrict access
to such services if managers and/or clinicians overestimate
these costs or if there is signiﬁcant uncertainty in such cost
estimates.
Measuring privately ﬁnanced resources and time devoted
to caregiving is essential because the work dedicated by
family members in the home environment is intense,
particularly as the patient nears death [5–10]. Several
empirical studies have indicated that families report end-of-
life caregiving to be psychosocially demanding [9–24]a n d
ﬁnancially straining [9, 10, 12, 21, 23, 25–27]. Measurement
of family member costs is diﬃcult for a number of reasons.
Research in this area is costly as it requires prospective design
to accurately assess caregiver time and costs. Furthermore,
recruitment ofcaregiverparticipants is particularly challeng-
ing as many caregivers are already overtaxed caring for their
terminally ill family member, thus less likely to agree to
participate, and consequently, those that do participate are
likely to be ones that experience less intensive caregiving
responsibilities. However, excluding patient and caregiver
resource costs in such studies underestimates the value and
type of resources consumed in various health care settings,
thusit is important that studiesare designed in such a way to
overcome and minimize these barrier and potential biases.
A systematic literature review was conducted to identify
original studies that have assessed economic outcomes in
end-of-life care. PubMed and MEDLINE were searched
(period = 1998–2009). The key word terms used were
“Palliative care” AND “costs” AND [“terminal care” OR
“utilization” OR “ﬁnancial outcomes” OR “hospice” OR
“home care”]. In addition, several journals that were directly
relevant to the topic were also examined. Finally, a snow-
balling technique was implemented whereby references cited
in the relevant articles were examined and included if
they proved relevant to the research topic. Articles were
excluded from search results if not speciﬁc to end-of-life
care, if cost measurement was not the primary focus, or
if cost analysis was limited to a particular component of
palliative care (e.g., speciﬁc treatment, speciﬁc service use).
This search strategy resulted in the identiﬁcation of 18
studies investigating economic outcomes of end-of-life care.
We approach our discussion of these studies herein by
identifying which cost categorieshave been considered; these
studies are represented in Table 1.
Most studies that measured in-patient costs attributable
to end-of-life care have been designed to assess cost savings
associated with the implementation of new in-patient end-
of-life care programs [31, 32, 37, 39] or interventions
[28, 30, 33, 36]. These studies captured only public costs
from a health system perspective and over a relatively short
period from hospital admission until death. In contrast,
Oliver and colleagues [35] conducted a more complete
assessment of the in-patient costs of all hospitalizations from
the time of initial cancer diagnosis until death. Although
this study provided insight into hospital costs at various
points over the illness trajectory, it did not capture home
and ambulatory costsbetween hospitalizations and itdid not
address out-of-pocket or time costs borne by patients and
their families/friends.
Studies which have assessed the cost of home-based end-
of-life care have either compared home-based programs to
institutionally based end-of-life care or to regular home-
based care [3, 4, 29, 38], looked at changes in costs after the
introduction of home-based end-of-life care programs [40],
or measured costs of a home-based palliative care program
[34]. Only one of these six studies that exclusively measured
home-based health system costs included all aspects of
public system expenditures [4]; however, an important
component of overall costs (i.e., private costs) was excluded.
In three studies, only staﬀ time dedicated to end-of-life
care was included and other health system costs, such as
laboratory/diagnostic tests [3, 29, 40]a n dm e d i c a t i o n s[ 3,
29] were excluded. One pilot study measured all public
expenditures of ambulatory health system costs associated
with a home-based palliative program, but did not include
private expenditures [34]. In addition, in one study, health
system costs were measured by assessing budgeted resource
use prior to the implementation of a home-based program
[40].Asthesesixstudiesonlyemphasize publichealthsystem
costs, they underestimate the full range of economic costs
incurred. Out-of-pocket expenditures for medications, care
providers,andtravelexpenses,aswellastimecostsassociated
with the receipt and provision of formal and informal health
care services may be substantial contributors to overall costs.
In two other studies, both public and private costs
associated with home-based end-of-life care were measured
[5, 6]; however, not all relevant components were captured.
In both of these studies, system costs were comprehensively
measured along with families’ out-of-pocket health care
expenses. Oneassessed only privatelyﬁnanced appointments
and out-of-pocket costs [5], while the other measured only
out-of-pocket costs and labor market time losses [6]. Since
time lost from household work or leisure was not assessed,
the full economic contribution of caregivers to home-based
end-of-life care was not captured.
One recently published study assessed both hospital and
home-based end-of-life care costs from a societal perspective
in ﬁve diﬀerent regions across Canada [7]. Although this
study provides insight into end-of-life care costs, there were
two categories that were not captured. Time missed from the
labourmarketwasnotcaptured,leavinglostincomeforcare-
givers as well as costs incurred by employers missing. Fur-
thermore, this study did not assess resource costs covered by
thirdpartyinsurance.Inaddition,caregivers’timedevotedto
caregiving was measured by asking respondents to report an
estimate of a typical day over the past 2 weeks, not allowing
for variation in caregivers’ during the two-week period.Journal of Aging Research 3
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b
e
n
d
e
r
e
t
a
l
.
[
2
]
R
e
t
r
o
s
p
e
c
t
i
v
e
r
e
v
i
e
w
(
a
d
m
i
n
i
s
t
r
a
t
i
v
e
d
a
t
a
b
a
s
e
s
)
t
o
e
v
a
l
u
a
t
e
h
e
a
l
t
h
s
y
s
t
e
m
c
o
s
t
s
o
f
p
a
l
l
i
a
t
i
v
e
c
a
r
e
b
e
f
o
r
e
a
n
d
a
f
t
e
r
i
m
p
l
e
m
e
n
t
a
t
i
o
n
o
f
a
c
o
m
m
u
n
i
t
y
-
b
a
s
e
d
p
a
l
l
i
a
t
i
v
e
c
a
r
e
s
e
r
v
i
c
e
(
C
a
n
a
d
a
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
c
o
m
m
u
n
i
t
y
c
a
r
e
,
i
n
-
p
a
t
i
e
n
t
,
p
h
y
s
i
c
i
a
n
,
a
n
d
m
e
d
i
c
a
t
i
o
n
s
.
×
×
G
´
o
m
e
z
-
B
a
t
i
s
t
e
e
t
a
l
.
[
3
2
]
P
r
o
s
p
e
c
t
i
v
e
m
u
l
t
i
c
e
n
t
r
e
s
t
u
d
y
t
o
c
o
m
p
a
r
e
i
n
-
p
a
t
i
e
n
t
c
o
s
t
s
a
n
d
r
e
s
o
u
r
c
e
u
t
i
l
i
z
a
t
i
o
n
o
f
a
p
a
l
l
i
a
t
i
v
e
c
a
r
e
s
e
r
v
i
c
e
c
o
m
p
a
r
e
d
w
i
t
h
h
i
s
t
o
r
i
c
a
l
d
a
t
a
p
r
i
o
r
t
o
i
m
p
l
e
m
e
n
t
a
t
i
o
n
o
f
t
h
e
s
e
r
v
i
c
e
(
S
p
a
i
n
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
i
n
-
p
a
t
i
e
n
t
a
c
u
t
e
c
a
r
e
,
i
n
-
p
a
t
i
e
n
t
p
a
l
l
i
a
t
i
v
e
c
a
r
e
,
E
D
v
i
s
i
t
s
,
p
a
l
l
i
a
t
i
v
e
c
a
r
e
o
u
t
p
a
t
i
e
n
t
c
l
i
n
i
c
,
p
h
y
s
i
c
i
a
n
v
i
s
i
t
s
.
×
×
H
a
n
s
o
n
e
t
a
l
.
[
3
3
]
P
r
o
s
p
e
c
t
i
v
e
c
a
s
e
-
c
o
n
t
r
o
l
s
t
u
d
y
t
o
d
e
t
e
r
m
i
n
e
t
h
e
i
m
p
a
c
t
o
f
p
a
l
l
i
a
t
i
v
e
c
a
r
e
c
o
n
s
u
l
t
a
t
i
o
n
s
o
n
h
o
s
p
i
t
a
l
c
o
s
t
s
o
f
t
e
r
m
i
n
a
l
l
y
i
l
l
h
o
s
p
i
t
a
l
i
z
e
d
p
a
t
i
e
n
t
s
(
U
S
A
)
.
T
o
t
a
l
h
o
s
p
i
t
a
l
c
o
s
t
s
,
l
e
n
g
t
h
o
f
s
t
a
y
,
a
v
e
r
a
g
e
d
a
i
l
y
c
o
s
t
s
.
×
J
o
h
n
s
o
n
e
t
a
l
.
[
3
4
]
P
i
l
o
t
s
t
u
d
y
t
o
e
v
a
l
u
a
t
e
s
e
r
v
i
c
e
u
s
e
a
n
d
c
o
s
t
s
o
f
a
h
o
m
e
-
b
a
s
e
d
p
a
l
l
i
a
t
i
v
e
c
a
r
e
p
r
o
g
r
a
m
(
C
a
n
a
d
a
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
p
e
r
s
o
n
n
e
l
s
u
p
p
o
r
t
,
l
a
b
o
r
a
t
o
r
y
t
e
s
t
s
,
n
u
r
s
i
n
g
v
i
s
i
t
s
,
n
u
t
r
i
t
i
o
n
a
l
c
o
u
n
s
e
l
i
n
g
,
o
c
c
u
p
a
t
i
o
n
a
l
t
h
e
r
a
p
y
,
m
e
d
i
c
a
l
s
u
p
p
l
i
e
s
a
n
d
e
q
u
i
p
m
e
n
t
,
m
e
d
i
c
a
t
i
o
n
s
.
×
O
l
i
v
e
r
e
t
a
l
.
[
3
5
]
A
r
e
t
r
o
s
p
e
c
t
c
h
a
r
t
a
n
a
l
y
s
i
s
t
o
d
e
t
e
r
m
i
n
e
r
e
s
o
u
r
c
e
u
s
e
a
n
d
c
o
s
t
s
o
f
p
a
t
i
e
n
t
s
d
i
a
g
n
o
s
e
d
w
i
t
h
s
m
a
l
l
l
u
n
g
c
e
l
l
c
a
r
c
i
n
o
m
a
f
r
o
m
d
i
a
g
n
o
s
i
s
u
n
t
i
l
d
e
a
t
h
(
U
n
i
t
e
d
K
i
n
g
d
o
m
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
i
n
-
p
a
t
i
e
n
t
d
a
y
s
,
o
u
t
p
a
t
i
e
n
t
v
i
s
i
t
s
,
i
n
v
e
s
t
i
g
a
t
i
o
n
s
,
l
a
b
o
r
a
t
o
r
y
t
e
s
t
s
,
m
e
d
i
c
a
t
i
o
n
s
,
r
a
d
i
o
t
h
e
r
a
p
y
f
r
a
c
t
i
o
n
s
,
h
o
s
p
i
c
e
i
n
-
p
a
t
i
e
n
t
d
a
y
s
a
n
d
o
u
t
p
a
t
i
e
n
t
v
i
s
i
t
s
,
c
o
m
m
u
n
i
t
y
n
u
r
s
i
n
g
v
i
s
i
t
s
,
s
o
c
i
a
l
s
e
r
v
i
c
e
s
u
p
p
o
r
t
c
o
n
s
u
l
t
a
t
i
o
n
s
.
×
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T
a
b
l
e
1
:
C
o
n
t
i
n
u
e
d
.
P
u
b
l
i
c
P
r
i
v
a
t
e
S
t
u
d
y
(
A
u
t
h
o
r
s
’
N
a
m
e
s
)
E
c
o
n
o
m
i
c
s
t
u
d
y
o
b
j
e
c
t
i
v
e
s
a
n
d
d
e
s
i
g
n
H
e
a
l
t
h
s
e
r
v
i
c
e
u
t
i
l
i
z
a
t
i
o
n
/
m
e
a
s
u
r
e
d
c
o
s
t
s
I
n
-
p
a
t
i
e
n
t
H
o
m
e
a
n
d
a
m
b
u
l
a
t
o
r
y
O
u
t
-
o
f
-
p
o
c
k
e
t
T
i
m
e
l
o
s
s
e
s
(
l
a
b
o
u
r
m
a
r
k
e
t
)
T
i
m
e
l
o
s
s
e
s
(
H
o
u
s
e
h
o
l
d
w
o
r
k
/
l
e
i
s
u
r
e
)
T
h
i
r
d
p
a
r
t
y
i
n
s
u
r
a
n
c
e
P
e
n
r
o
d
e
t
a
l
.
[
3
6
]
R
e
t
r
o
s
p
e
c
t
i
v
e
a
n
a
l
y
s
i
s
o
f
a
d
m
i
n
i
s
t
r
a
t
i
v
e
d
a
t
a
t
o
e
x
a
m
i
n
e
h
o
s
p
i
t
a
l
u
t
i
l
i
z
a
t
i
o
n
a
n
d
d
i
r
e
c
t
c
o
s
t
s
o
f
a
p
a
l
l
i
a
t
i
v
e
c
a
r
e
c
o
n
s
u
l
t
a
t
i
o
n
p
r
o
g
r
a
m
i
n
c
o
m
p
a
r
i
s
o
n
t
o
u
s
u
a
l
c
a
r
e
i
n
t
w
o
c
e
n
t
e
r
s
(
U
S
A
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
L
O
S
,
I
C
U
L
O
S
,
m
e
d
i
c
a
l
s
u
p
p
l
i
e
s
,
l
a
b
o
r
a
t
o
r
y
a
n
d
r
a
d
i
o
l
o
g
y
s
e
r
v
i
c
e
s
,
p
h
y
s
i
c
i
a
n
,
n
u
r
s
i
n
g
,
c
o
n
t
r
a
c
t
,
a
n
d
a
l
l
o
t
h
e
r
l
a
b
o
u
r
.
×
S
h
n
o
o
r
e
t
a
l
.
[
5
]
R
e
t
r
o
s
p
e
c
t
i
v
e
c
a
s
e
-
c
o
n
t
r
o
l
c
o
s
t
a
n
a
l
y
s
i
s
o
f
p
a
t
i
e
n
t
s
r
e
c
e
i
v
i
n
g
h
o
m
e
h
o
s
p
i
c
e
s
e
r
v
i
c
e
s
i
n
c
o
m
p
a
r
i
s
o
n
t
o
c
o
n
v
e
n
t
i
o
n
a
l
h
e
a
l
t
h
s
e
r
v
i
c
e
s
i
n
t
h
e
t
w
o
m
o
n
t
h
s
p
r
i
o
r
t
o
d
e
a
t
h
(
I
s
r
a
e
l
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
m
e
d
i
c
a
t
i
o
n
s
,
l
a
b
o
r
a
t
o
r
y
t
e
s
t
s
,
r
a
d
i
o
g
r
a
p
h
s
,
i
m
a
g
i
n
g
,
h
o
m
e
a
n
d
h
o
s
p
i
t
a
l
p
r
o
c
e
d
u
r
e
s
,
m
e
d
i
c
a
l
e
q
u
i
p
m
e
n
t
,
i
n
-
p
a
t
i
e
n
t
d
a
y
s
,
E
D
v
i
s
i
t
s
,
s
u
r
g
i
c
a
l
p
r
o
c
e
d
u
r
e
s
,
a
n
y
o
t
h
e
r
t
r
e
a
t
m
e
n
t
f
o
r
w
h
i
c
h
t
h
e
s
e
r
v
i
c
e
p
r
o
v
i
d
e
r
s
w
e
r
e
p
a
i
d
.
×
×
×
×
S
m
i
t
h
e
t
a
l
.
[
3
7
]
C
a
s
e
-
c
o
n
t
r
o
l
s
t
u
d
y
t
o
m
e
a
s
u
r
e
t
h
e
c
o
s
t
o
f
c
a
r
e
i
n
a
d
e
d
i
c
a
t
e
d
i
n
-
p
a
t
i
e
n
t
p
a
l
l
i
a
t
i
v
e
c
a
r
e
u
n
i
t
.
D
a
i
l
y
c
o
s
t
s
o
f
t
h
e
p
a
l
l
i
a
t
i
v
e
c
a
r
e
u
n
i
t
w
e
r
e
c
o
m
p
a
r
e
d
t
o
i
n
-
p
a
t
i
e
n
t
c
o
s
t
s
p
r
i
o
r
t
o
t
r
a
n
s
f
e
r
t
o
u
n
i
t
,
a
s
w
e
l
l
a
s
t
o
p
a
t
i
e
n
t
s
w
h
o
d
i
e
d
u
s
i
n
g
c
o
n
v
e
n
t
i
o
n
a
l
m
e
d
i
c
a
l
s
e
r
v
i
c
e
s
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
d
a
i
l
y
c
h
a
r
g
e
s
i
n
-
p
a
t
i
e
n
t
a
n
d
c
o
s
t
s
o
f
d
a
y
s
p
r
i
o
r
t
o
t
r
a
n
s
f
e
r
t
o
p
a
l
l
i
a
t
i
v
e
c
a
r
e
u
n
i
t
.
×
T
a
m
i
r
e
t
a
l
.
[
3
8
]
R
e
t
r
o
s
p
e
c
t
i
v
e
r
e
v
i
e
w
o
f
a
d
m
i
n
i
s
t
r
a
t
i
v
e
d
a
t
a
b
a
s
e
s
t
o
c
o
m
p
a
r
e
h
e
a
l
t
h
s
e
r
v
i
c
e
u
t
i
l
i
z
a
t
i
o
n
d
u
r
i
n
g
t
h
e
l
a
s
t
y
e
a
r
o
f
l
i
f
e
i
n
p
a
t
i
e
n
t
s
r
e
c
e
i
v
i
n
g
h
o
m
e
-
s
p
e
c
i
a
l
i
z
e
d
p
a
l
l
i
a
t
i
v
e
c
a
r
e
w
i
t
h
n
o
n
s
p
e
c
i
a
l
i
z
e
d
c
a
r
e
(
I
s
r
a
e
l
)
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
a
m
b
u
l
a
t
o
r
y
p
r
o
c
e
d
u
r
e
s
,
l
a
b
o
r
a
t
o
r
y
,
i
m
a
g
i
n
g
,
c
o
n
s
u
l
t
a
t
i
o
n
s
,
i
n
-
p
a
t
i
e
n
t
c
o
s
t
s
a
n
d
L
O
S
,
E
D
v
i
s
i
t
s
,
p
h
y
s
i
c
i
a
n
v
i
s
i
t
s
,
o
n
c
o
l
o
g
y
t
r
e
a
t
m
e
n
t
s
.
×
×
W
h
i
t
e
e
t
a
l
.
[
3
9
]
L
o
n
g
i
t
u
d
i
n
a
l
c
a
s
e
s
t
u
d
y
t
o
m
e
a
s
u
r
e
c
o
s
t
s
o
f
a
h
o
s
p
i
t
a
l
-
b
a
s
e
d
p
a
l
l
i
a
t
i
v
e
c
a
r
e
u
n
i
t
i
n
t
h
e
2
0
d
a
y
s
p
r
i
o
r
t
o
d
e
a
t
h
.
C
o
s
t
s
o
f
c
a
r
e
w
e
r
e
c
o
m
p
a
r
e
d
b
e
t
w
e
e
n
t
h
e
p
a
l
l
i
a
t
i
v
e
c
a
r
e
u
n
i
t
,
t
h
e
I
C
U
,
a
n
d
o
t
h
e
r
u
n
i
t
s
.
M
e
a
s
u
r
e
d
c
o
s
t
s
:
a
v
e
r
a
g
e
c
o
s
t
p
e
r
d
a
y
o
f
p
a
t
i
e
n
t
s
w
h
o
d
i
e
d
i
n
t
h
e
h
o
s
p
i
t
a
l
.
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None of the aforementioned studies utilized an instru-
ment that had been standardized and evaluated. As in all
aspects of methodology, the use of a standardized and
evaluated questionnaire supports the validity and reliability
of the study results.
3.FrameworkforMeasuringHome-Based
End-of-LifeCosts
We propose the use of the Ambulatory and Home Care
Record (AHCR), a standardized and comprehensive frame-
work and tool, to measure costs within the end-of-life
context from a societal perspective [2–4] (see Appendix).
This approachgivesequalconsiderationtocostsbornebythe
health system as well as those costs borne by care recipients
andinformal caregivers,suchas familymembers andfriends.
This perspective values out-of-pocket expenses as well as
time devotedto caregiving [36, 41]. The importance given to
such caregiving time is based on the premise that such time
may have been used in otheractivities such as market labour,
leisure, or household work, and hence represent foregone
opportunities[3].Thisisconsideredamajoradvantagegiven
that time costs can represent a signiﬁcant proportion of total
healthcare costs [42].
The AHCR was developed in 1997 by the authors in
response to the gaps and inconsistency of systematic eco-
nomic evaluations in assessing health system costs associated
with ambulatory and home-based health services. Items
for the questionnaire were determined through research
with economics literature and focus groups with health
economists, health care professionals, and patients within
both pediatric and adult settings. Its content validity was
further evaluated with a panel of experts and revisions were
made accordingly.
The AHCRis designed as a prospective tool which can be
self-administered orcompletedin aface-to-face ortelephone
interview. An electronic version of the AHCR has been
developed to facilitate real-time data entry and to expedite
the valuation process. The psychometric properties of the
AHCR in collecting publicly ﬁnanced health services was
evaluated with a cohort of cystic ﬁbrosis patients where
prospective self-administered AHCR reports were compared
with administrative data; agreement ranged from moderate
to perfect (kappa −0.41–1.0) [43]. Since inception, the
AHCR has been used for a range of clients by age, care
setting, and clinical condition, and in several countries
[42, 44–58]. Items in the AHCR are categorized as publicly
ﬁnanced expenditures or privately ﬁnanced expenditures
(Table 2). Publicly ﬁnanced expenditures include all costs
incurredbythepublicsectorintheorganizationand delivery
of health care services. Public expenditures comprise those
costs associated with the use of ambulatory services, in-
patient services, and home-based health services. Privately
ﬁnanced care includes all health care costs not publicly
insured and/or ﬁnanced. This includes third party insurance
payments, out-of-pocket payments by patients and their
families/friends, timecostsincurredbyfamilycaregivers,and
coststoemployerswhencaregiversare absentfrom thework-
place. Third party insurance refers to the amount of money
Table 2: Framework for the assessmentof end-of-life costs.
Expenditure category Resource
PUBLIC
(i) Ambulatory
Health care professional appointments
Clinic visits
Laboratory and diagnostic tests
Treatment (chemotherapy and radiation)
Medications
Supplies and equipment
Emergency room visits
(ii) In-patient
Hospitalizations
Nursing home
Hospice care
(iii) Home
H o m eC a r e :n u r s i n g ,p e r s o n a ls u p p o r t /
homemaking, occupational therapy,
physiotherapy, oxygen therapy, diagnostic
tests
PRIVATE
(i) 3rd Party insurance
Health care appointments
Medications
Hospitalizations
Supplies and equipment
(ii) Out-Of-Pocket
Health care professional appointments
Home caregivers
Travel expenses
Medications
Supplies and equipment
Insurance payments
(iii) Caregiver Time
Losses
Time devoted by family/friends
to caregiving v(i) Time lost
from paid market labour
(ii) Time lost from leisure/house hold
work time
(iv) Employer Timemissedby employees who are family
caregivers
paid by insurance companies to cover healthcare services.
Private health insurance can be paid for by employers or
paid for by patients/families if they purchase it themselves.
Out-of-pocket costs include the amount of money paid by
families for consultations with healthcare professionals (not
covered by public funding), household help, medications,
supplies,travelexpenses,andprivateinsuranceexpenditures.
Caregiver time costs refer to the monetary value assigned to
time losses incurred by unpaid caregivers in relation to the
patient’s care (e.g., time spent caring for the patient, time
spent traveling to and from consultations). This lost time is
quantiﬁed in economic terms by assigning a monetary value
to lost time.
To value end-of-life resources, we access various sources.
Fee-for-service rate schedules are used to determine physi-
cian and laboratory service unit costs. Rates used for
resource expenditures by the relevant home care agencies
are employed to determine the cost of publicly ﬁnanced
home-based provider services. Medication costs paid for
by the government are derived using the public drugJournal of Aging Research 7
insurance formulary rate. Out-of-pocket costs incurred by
families are self-reported and any reimbursements received
from drug plans or medical insurance are subtracted from
these expenses. Hospitalizations are assigned to designated
case mix groups [59, 60], and valued in accordance with
associated resource intensity weights [61–63]. Finally, time
costs are assigned a monetary value using the human
capital approach [64]. This approach applies current average
earnings by age and gender to lost market time and imputes
the market value of time withdrawn from leisure and
household work. To value time lost from market labor,a g e -
/sex- based earnings estimates from the National Census are
used and adjusted for employer paid beneﬁts and vacation
days and holidays. Time lost from household work/leisure is
valued using the estimated earnings of a homemaker from
the National Census and adjusted for fringe beneﬁts, and
vacation days and holidays. Consequently, the valuation of
timelostisdependentonthesourcesofsuchcaregiving time,
that is, whether time is diverted from the labour market,
household work or leisure.
The AHCR has been used to evaluate two aspects of
end-of-life care and published in the literature [8]. First,
costs associated with a home-based end-of-life program in
two provinces in Canada [8] were assessed over the end-
of-life care trajectory, from time of admission into the
program until death. Second, data from the AHCR was
used to assess the predictors of place of death (home versus
institution) within a sample of patients enrolled in a home-
based program in Toronto [57]. Based on this data and
consideration of the extensive needs of the end-of-life care
discipline [21, 65–68], below we recommend a multitude of
economicresearch topicsthat require further study and their
importance.
It should be noted that other standardized costing tools
for use in medical patients are available. However, these
tools have not been developed in the context of end-of-life
care, thus pose several limitations for economic studies of
terminally ill palliative care patients.
4.Usesof EconomicOutcomeData Generated
bytheAHCRFramework
There areﬁvemain waysin which theAHCRmethodological
framework can be utilized to assess the end-of-life care
environment. These approaches are discussed in the ﬁve
sections below. The ACHR can be partnered with other data
collection instruments to ascertain a comprehensive assess-
ment of the overall home-based end-of-life environment,
and such data may be analyzed in a multitude of ways to
describetheeconomiccontextwithin which careisprovided.
We provide suggestions as to what types of questions can
be answered using this framework, while providing some
examples of our previous work, and how the information
may be used to inform practice.
4.1. Cost Category Comparisons. The data generated by the
AHCR can allow for a patient-level analysis. Each partici-
pant’s responses to the AHCR yield four subsets of resource
costs: (1) publicly ﬁnanced health system costs, (2) private
third party insurance expenditures, (3) privately ﬁnanced
out-of-pocket costs, and (4) private time costs. The four
cost categories can also be aggregated to yield total societal
costs. Assessments of and comparisons with other end-of-
life interventions and programs is feasible; comparisons can
be made between total societal cost and between subsets
of resource costs. Previous applications of the AHCR have
revealed that patient and family costs comprised a large
portion (from 65% to 72%) of the total costs associated with
ambulatory and home-based care [42, 47–56]. Although
these previous studies were conducted with patients/families
with a variety of chronic and acute conditions, these ﬁndings
highlight the important contribution of time costs to overall
costs in caregiving environments.
4.2. Private/Public Relationship. Measuring all relevant cost
categories in the end-of-life care context allows for the
examination of the relationship between private and public
expenditure and the determination of whether they substi-
tute or complement each other. In addition, it is possible to
examine the proportion of total costs associated with the key
end-of-life care components such as physician visits, nurse
visits, personal support worker visits, ambulatory physi-
cian appointments, and other home-based and ambulatory
appointments. This type of analysis would permit health
service planning and resource allocation within programs
and across sites of care.
4.3. Temporal Cost Assessment. A prospective approach to
measuring costsallows for a longitudinalassessment overthe
care trajectory. A comprehensive assessment of private and
public costs of both home and institutional costs over the
entire end-of-life care trajectory allows for an understanding
of how costs change over time, how they behave as patients
near death, and how possible changes in the intensity of care
provision might modify outcomes, such as place of death,
quality of life for patients and caregivers, and overall costs of
theepisodeofcare.Inourpreviouswork, wefoundthatcosts
increased exponentially as the care recipient approached
death [8]. Because caregivers provide a signiﬁcant amount
of care and are responsible for coordinating home-based
care, it is essential to obtain an understanding of the care
environmentinordertoensurethattheyarebeingsupported
in their eﬀorts. By characterizing the distribution of societal
costs, insight into the ﬁnancial burden experienced by
families throughout the end-of-life care trajectory can be
obtained. Such information oﬀe r st h ep o t e n t i a lt og a u g et h e
relationship between family caregiving activities and various
other cost components. Findings from this may be used to
identify a role for caregiving allowances and other forms
of caregiver support. This temporal assessment of costs has
the potential to inform policy as aspects of care may be
appropriately modiﬁed at each time point in the end-of-life
care trajectory.
4.4. Cost Predictors. The AHCR methodological framework
also permits the examination of factors that predict public8 Journal of Aging Research
and private resource utilization. Speciﬁcally, the sociode-
mographic and clinical factors that predict the propensity
and intensity of end-of-life service use and what predictors
are important at diﬀerent times in the trajectory can be
examined. For example, in our previous work, we found
that age, gender, living arrangement, activities of daily living
(ADL), number of chronic conditions, and the interaction
between both public expenditure and ADL level were
shown to increase private expenditures [42]. Furthermore,
in another study, we assessed predictors of end-of-life costs
[8]. Three variables were found to be signiﬁcant predictors
of total costs: time to death, functional status, and living
arrangement. Total societal costs increased as time to death
decreased. This observationwas expected because as patients
near death, their care needs increase, and consequently their
use of resources increases. Patients who had poorer func-
tionalstatus incurredgreater totalcostscomparedwith those
with better functional status. This was expected because as a
patients’ level of functioning falls, he/she requires more care,
thereby increasing resource costs. Patients who lived alone
had lower total costs than those who lived with others. It is
postulated that these higher costs are attributable to having
a caregiver who is more accessible to provide care, relative to
those not living with their caregiver.
4.5. Standardized Method for Economic Evaluation. System-
atic evaluation of the costs associated with the provision
and receipt of ambulatory and home-based health services
is an essential component of research aimed at determining
which interventions and sites of care are most cost-eﬀective.
The AHCR is a standardized resource and costing tool that
enables accurate comparisons of the resource implications
for diﬀerent services and for diverse patients. Application
of AHCR methods would enhance the eﬃciency with which
scarce resources in the area of end-of-life care are allocated.
5.Conclusions
The AHCR was developed in response to the need for
a standardized, comprehensive instrument to obtain and
value resources associated with ambulatory and home-based
healthprograms.TheAHCRallowsforagreaterappreciation
of the diﬀerences in end-of-life care costs between home
and hospital based services, and the relationship between
public and private expenditures. Application of the AHCR,
when used in conjunction with quality of life, caregiver
burden, and performance scales, can provide information
that will gauge the relationship between family caregiving
activities and other cost components within the home
setting. Issues concerning access to services, as well as their
quantity and quality can be highlighted. Understanding cost
implications may inform the targeting of services to those
patientsand theirfamilies. By measuring costslongitudinally
we can observe changes over end-of-life care trajectory.
This knowledge will indicate areas for resource shifting and
potential cost savings.
A lack of research in economic outcomes in end-of-life
care impedes informed decision-making by practitioners,
Table 3
Type of health care professional
(see list below)
Number of hours health care
professionalvisited
Nurse 2 hrs (6 visits)
Personal support worker 22 hrs (12 visits)
Examples of health care professional: nurse, palliative physician, personal
support worker, occupational therapist, physiotherapist,physician.
health managers, and policy decisions makers; it may give
rise to insuﬃcient levels of ﬁnancial support for patients
and caregivers when programs are unable to be transparent
and accountable for resources expended. AHCR ﬁndings
will help senior administrators and managers in monitoring
resource costs and the quality of home-based end-of-life
care. This framework can greatly beneﬁt: practitioners and
health managers of community-based end-of-life care teams
who aim to meet health and social care needs of patients;
managers at regional and local level who are responsi-
ble for resource allocation, program design, and quality
improvement;orpolicydecisionmakersengaged inprogram
evaluation,funding decisions, andwho are responding tothe
need for accountability.
Appendix
Ambulatoryand HomeCare Record
CoyteandGuerriere1998
(1) Health Care Appointments at Home [Does not Include
Any Health Care Professionals You Paid]. Which health care
professionals visited the patient at home in the past two
weeks, from [Start of interview period]t o[ End of interview
period]? (see Table 3).
(2) Health Care Appointments Outside the Home. Did the
patient see a health care professional outside of the home,
from [Start of interview period]t o[ End of interview period]?
(see Table 4).
(3) Care to the Patient by Paid Care Providers. Did you (or
another family member) pay money to anyone to care for the
patient at home, from [Start of interview period]t o[ End of
interview period]? (see Table 5).
(4) Medications/Supplies/Equipment. Did you (or another
family member) buy or receive supplies/equipment or buy
medicine (prescription or over-the-counter) for the patient,
from [Start of interview period]t o[ End of interview period]?
(see Table 6).
(5) Care to the Patient [Provided by You, Another Family
Member, Friend, Neighbour [Does not Include Anyone You
Paid]. What is the total number of hours you and your
family and other caregivers spent caring for the patient, from
[Start of interview period] to [End of interview period]? (see
Table 7).Journal of Aging Research 9
Table 4
Type(s) of visit (see
examples below) Method of travel
If by car Other travel costs, for example, taxi Other costs, for example, food
Total
distance
(Km)
Parking
costs Type Amount Type Amount
Oncologist Car 8 $23 — $ Food $5
Personal support
worker—
— — $ Taxi $40 — $
—— $ — — — $
Examples of visits: medical oncologist, radiation oncologist, family doctor, nurse, emergency room, physiotherapist, medical/lab test (please specify)
Examples of tests: blood test, X-rays, ultrasound, CT, MRI
Examples of methods of travel: car, public transit, taxi.
Table 5
Type of care
provider (see
examples below)
Total paid to care
provider
Will you be reimbursed for
this money? (yes or no) If
yes, indicate % or amount
reimbursed
Physiotherapist $75 80%
Personal support
worker $200/8 hrs No
Examples of Care provider: nurse, personal support worker, occupational therapist, physiotherapist.
Table 6
Name of medicine or
description of
equipment/supplies
(e.g., syringes,
thermometer)
Amount paid by you Provided by home care
agency. If equipment,
borrowed or given to
you to keep?
Total cost of medicine (including
dispensing fee) or
supplies/equipment
(rented/purchased)
Will you be reimbursed for this
money? (yes or no)
If yes, indicate % or amount
reimbursed
Acetaminophen $10 No No
Nutritional Drinks $13 Yes (90%) No
Table 7
Care provider age/male
(M) or female (F)
Total number of hours
you/care provider spent
providing care over the
past 2 weeks
Number of hours you/care provider took away from employment over the past 2 weeks
Unpaid leave Sick leave Vacation time
Female/50 yrs old 42 — — 7.5 hrs
Male/70 yrs old 70 N/A N/A N/A
∗NA: Not applicable because care provider is not employed outside the home.
Examples of care: traveling to and attending health care appointments, suctioning, resting, changing a dressing, feeding.
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